CPA
LMAT icon

Capital Performance Advisors’s LeMaitre Vascular LMAT Stock Holding History

Capital Performance Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-33
Closed -$3.06K – 1552
2024
Q3 		$3.06K Buy
+33
New +$2.86K ﹤0.01% 1349

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Performance Advisors's LMAT Position: Q4 2024 in Review

Capital Performance Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2024, closing a stake of 33 shares — an estimated $3.06K sold.

Capital Performance Advisors first reported a position in LMAT in Q3 2024 and held it in 1 quarter. The position peaked at $3.06K in Q3 2024. 307 funds tracked by Wall St. Rank hold LMAT as of Q4 2024.

  • Capital Performance Advisors reported no remaining LeMaitre Vascular position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 33 LeMaitre Vascular shares in Q4 2024, an estimated $3.06K.
  • Capital Performance Advisors first reported a position in LeMaitre Vascular in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's LeMaitre Vascular position peaked at $3.06K in Q3 2024.
  • 307 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.